Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lolies, Marco"'
Autor:
Niesel, Katja, Schulz, Michael, Anthes, Julian, Alekseeva, Tijna, Macas, Jadranka, Salamero-Boix, Anna, Möckl, Aylin, Oberwahrenbrock, Timm, Lolies, Marco, Stein, Stefan, Plate, Karl, Reiss, Yvonne, Rödel, Franz, Sevenich, Lisa
The tumor microenvironment in brain metastases is characterized by high myeloid cell content associated with immune suppressive and cancer-permissive functions. Moreover, brain metastases induce the recruitment of lymphocytes. Despite their presence,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c331fb3b14a35cb0548484a7d6869a27
https://publica.fraunhofer.de/handle/publica/269204
https://publica.fraunhofer.de/handle/publica/269204
The immune suppressive microenvironment affects efficacy of radio-immunotherapy in brain metastasis.
Autor:
Niesel K; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany., Schulz M; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany.; Biological Sciences, Faculty 15, Goethe University Frankfurt, Frankfurt am Main, Germany., Anthes J; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany., Alekseeva T; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany., Macas J; Institute of Neurology (Edinger Institute), University Hospital, Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt am Main, Germany., Salamero-Boix A; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany.; Biological Sciences, Faculty 15, Goethe University Frankfurt, Frankfurt am Main, Germany., Möckl A; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany., Oberwahrenbrock T; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Frankfurt am Main, Germany.; Fraunhofer Cluster of Excellence Immune Mediated Diseases (CIMD), Frankfurt am Main, Germany., Lolies M; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany., Stein S; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany., Plate KH; Institute of Neurology (Edinger Institute), University Hospital, Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany., Reiss Y; Institute of Neurology (Edinger Institute), University Hospital, Goethe University, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany., Rödel F; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiotherapy and Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany., Sevenich L; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2021 May 07; Vol. 13 (5), pp. e13412. Date of Electronic Publication: 2021 Mar 23.
